Monthly Archives: October 2024

In the summer, we wrote about the newest pneumococcal vaccine approved in the United States.  It is now available in Canada and is called Capvaxive and is manufactured by Merck. There are about 100 types of pneumococcal bacteria.  Capvaxive protects … Continue reading →

As newer biologic medicines can be incredibly useful in managing many conditions (e.g. immune-mediated, bone disorders, diabetes), their use can be limited by cost.  The introduction of biosimilars, however, has offered biologic medicines that are just as safe and effective … Continue reading →